Kang, N.; Ma, J.; Hu, Y.; Di, R.; Wang, L.; Zhang, X.; Lai, Y.; Liu, Y.
Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA−24 with Tumor-Selective Toxicity. Pharmaceuticals 2024, 17, 291.
https://doi.org/10.3390/ph17030291
AMA Style
Kang N, Ma J, Hu Y, Di R, Wang L, Zhang X, Lai Y, Liu Y.
Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA−24 with Tumor-Selective Toxicity. Pharmaceuticals. 2024; 17(3):291.
https://doi.org/10.3390/ph17030291
Chicago/Turabian Style
Kang, Nannan, Jun Ma, Yuling Hu, Rongrong Di, Lei Wang, Xuanling Zhang, Yisheng Lai, and Yu Liu.
2024. "Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA−24 with Tumor-Selective Toxicity" Pharmaceuticals 17, no. 3: 291.
https://doi.org/10.3390/ph17030291
APA Style
Kang, N., Ma, J., Hu, Y., Di, R., Wang, L., Zhang, X., Lai, Y., & Liu, Y.
(2024). Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA−24 with Tumor-Selective Toxicity. Pharmaceuticals, 17(3), 291.
https://doi.org/10.3390/ph17030291